DAWN (DAWN)
Day One Biopharmaceuticals, Inc.
NASDAQ:DAWNHealthcare · Biotechnology
Mkt Cap-
Float76.45M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$158.18M
Net Income-$107.32M
Total Assets$507.83M
Free Cash Flow-$104.08M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$2.79M
Total Equity$441.16M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in DAWN's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$507.83M
Liabilities$66.67M
Accounts Receivable$26.73M
Accounts Payable$3.73M
Inventory$6.33M
PP&E (Net)$4.48M
Goodwill$0
Intangible Assets$18.02M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $158.18M | $131.16M | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | 20.6% | - | - | - | - | - | - |
| Cost of Revenue | $17.21M | $5.28M | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $140.97M | $125.88M | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | 89.1% | 96.0% | - | - | - | - | - |
| Research and Development | $148.13M | $227.7M | $130.52M | $85.62M | $43.58M | $9.1M | $13.9M |
| Selling, General, and Administrative | $120.59M | $115.45M | $75.54M | $61.29M | $29.16M | $4.68M | $1.01M |
| Other | $0 | $0 | $0 | $0 | $0 | -$31K | $0 |
| Total Operating Expenses | $268.72M | $343.15M | $206.06M | $146.91M | $72.74M | $13.78M | $14.9M |
| Operating Income (EBIT) | -$127.75M | -$217.27M | -$206.06M | -$146.91M | -$72.74M | -$13.78M | -$14.9M |
| Operating Margin | -80.8% | -165.7% | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $30K | $2.08M |
| Interest Income | $18.47M | $19.7M | $17.19M | $4.75M | $4K | $0 | $0 |
| Other Income (Expense) | $18.45M | $128.92M | $17.15M | $4.73M | -$11K | -$30.03M | -$2.08M |
| Income Before Tax (EBT) | -$109.3M | -$88.35M | -$188.92M | -$142.18M | -$72.75M | -$43.84M | -$16.98M |
| Income Tax Expense | -$1.98M | $7.14M | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$107.32M | -$95.5M | -$188.92M | -$142.18M | -$70.64M | -$40.51M | -$12.63M |
| Net Income Margin | -67.8% | -72.8% | - | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -1.04 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Diluted EPS | -1.04 | -1.02 | -2.37 | -2.02 | -1.14 | -0.65 | -0.24 |
| Weighted Average OS | 103.38M | 93.62M | 79.77M | 65.47M | 61.95M | 61.93M | 61.93M |
| EBITDA | -$105.51M | -$86.32M | -$188.53M | -$141.65M | -$72.56M | $16.37M | -$2K |
| EBITDA Margin | -66.7% | -65.8% | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $197.08M | $124.97M | $230.78M | $85.26M | $284.31M | $43.73M | $27.33M |
| Short-Term Investments | $244.03M | $406.75M | $135.56M | $257.01M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $441.11M | $531.72M | $366.35M | $342.27M | $284.31M | $43.73M | $27.33M |
| Accounts Receivable | $26.73M | $13.88M | $0 | $0 | $0 | $0 | $0 |
| Inventory | $6.33M | $3.32M | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3.68M | $4.37M | $2.35M | $1.01M | $1.01M | $1.26M | $0 |
| Total Current Assets | $485.1M | $562.33M | $375.27M | $347.87M | $289.37M | $45.07M | $27.34M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $4.48M | $4.71M | $560K | $719K | $284K | $483K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $18.02M | $15.63M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $230K | $121K | $214K | $469K | $169K | $107K | $0 |
| Total Long-Term Assets | $22.73M | $20.46M | $774K | $1.19M | $453K | $590K | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $507.83M | $582.79M | $376.05M | $349.06M | $289.82M | $45.66M | $27.34M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $3.73M | $3.26M | $2.58M | $260K | $1.74M | $202K | $69K |
| Short-Term Debt | $0 | $10K | $408K | $405K | $204K | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $2M | $1.55M | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $672K | $54.68M | $17.36M | $9.82M | $104K | $27K | $1.49M |
| Total Current Liabilities | $60.52M | $73.45M | $29.51M | $16.61M | $8.66M | $2M | $2.02M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $3.04M | $3.23M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $484K | $761K | $0 | $0 | $0 | $0 | $30.5M |
| Total Long-Term Liabilities | $6.14M | $6.59M | $0 | $408K | $16K | $204K | $30.5M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $66.67M | $80.04M | $29.51M | $17.02M | $8.67M | $2.2M | $32.52M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $91.96M | $5.49M |
| Common Stock | $10K | $10K | $9K | $7K | $6K | $2.64M | $2M |
| Retained Earnings | -$661.4M | -$554.08M | -$458.58M | -$269.67M | -$127.49M | -$56.84M | -$12.78M |
| Comprehensive Income & Other | $65K | $84K | $9K | -$71K | $0 | $0 | $111 |
| Other Stockholders' Equity | $1.1B | $1.06B | $805.12M | $601.7M | $408.63M | $91.96M | $111K |
| Total Equity | $441.16M | $502.75M | $346.54M | $332.04M | $281.15M | $37.76M | -$10.67M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $5.7M | $5.49M |
| Total Liabilities and Equity | $507.83M | $582.79M | $376.05M | $349.06M | $289.82M | $39.96M | $21.85M |
| Supplementary Data | |||||||
| Total Debt | $2.79M | $2.6M | $408K | $813K | $220K | $402K | $0 |
| Net Debt | -$194.28M | -$122.37M | -$230.38M | -$84.45M | -$284.09M | -$43.33M | -$27.33M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$107.32M | -$95.5M | -$188.92M | -$142.18M | -$72.75M | -$43.84M | -$16.98M |
| Depreciation & Amortization | $3.79M | $2.03M | $383K | $531K | $199K | $155K | $14.9M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $44.39M | $48.26M | $39.34M | $27.24M | $13.32M | $526K | $111K |
| Changes in Working Capital: | |||||||
| Accounts Receivable | -$12.86M | -$13.88M | $0 | $0 | $0 | $0 | $0 |
| Inventory | -$2.86M | -$3.24M | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $471K | $686K | $2.32M | -$1.48M | $1.54M | $132K | $14K |
| Other Working Capital | -$13.69M | $42.91M | $7.1M | $8.05M | $1.15M | -$489K | $430K |
| Total Working Capital Change | -$28.94M | $26.48M | $9.42M | $6.56M | $2.69M | -$357K | $444K |
| Other Non-Cash Items | -$15.67M | -$59.39M | -$7.08M | -$2.03M | $8M | $30.03M | -$2.99M |
| Net Cash from Operating | -$103.76M | -$78.11M | -$146.85M | -$109.87M | -$48.54M | -$13.49M | -$4.51M |
| Investing Activities | |||||||
| Capital Expenditures | -$320K | -$2.17M | -$224K | -$26K | -$8M | -$92K | $0 |
| Acquisitions | $0 | $0 | $0 | $255K | $0 | $0 | $0 |
| Purchases of Investments | -$695.81M | -$658.62M | -$443.84M | -$394.21M | $0 | $0 | $0 |
| Sales of Investments | $874.25M | $393.89M | $575.44M | $139.16M | $0 | $0 | $0 |
| Other Investing Activities | -$3.47M | $35.9M | -$3M | -$255K | $0 | $0 | $0 |
| Net Cash from Investing | $174.65M | -$230.99M | $128.38M | -$255.07M | -$8M | -$92K | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | - | - | -$1M |
| Common Stock Issuance | $1.22M | $178.18M | $161.41M | $161.61M | $167.04M | $29.98M | $29.91M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $25.11M | $0 | $4.29M | $318K | $0 | $0 |
| Net Cash from Financing | $1.22M | $203.29M | $164M | $165.9M | $297.12M | $29.98M | $30.91M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $72.11M | -$105.82M | $145.52M | -$199.05M | $240.58M | $16.4M | $26.39M |
| Supplementary Data | |||||||
| Operating Cash Flow | -$103.76M | -$78.11M | -$146.85M | -$109.87M | -$48.54M | -$13.49M | -$4.51M |
| Capital Expenditure | -$320K | -$2.17M | -$3.22M | -$26K | -$8M | -$92K | $0 |
| Free Cash Flow | -$104.08M | -$80.28M | -$150.08M | -$109.9M | -$56.54M | -$13.58M | -$4.51M |
| Cash at Beginning | $124.97M | $230.78M | $85.26M | $284.31M | $43.73M | $27.33M | $942K |
| Cash at End | $197.08M | $124.97M | $230.78M | $85.26M | $284.31M | $43.73M | $27.33M |